Founded in 2016, Biomedica is driven by the core philosophy of "Simple & Precise," aiming to promote AI precision medical technologies and contribute to addressing the challenges of a rapidly aging global society. Beyond focusing on the local market, we actively expand overseas, achieving medical certifications and market development in thirteen countries, including Vietnam, Singapore, Thailand, Malaysia, Indonesia, the Philippines, Japan, and South Korea. Our goal is to become the leading osteoporosis solution provider in the Asia-Pacific region.

We specialize in developing AI-powered disease screening products, with a focus on "New Era Women's Health." Guided by the concept of "Six Seconds to a Safer Tomorrow," we provide fast and simple screening services. Our technologies include solutions for osteoporosis, sarcopenia, and genetic testing, emphasizing early diagnosis to safeguard women’s health. Through user-friendly AI screening software, we offer precise solutions for healthcare professionals and researchers, addressing the challenges of disease detection and advancing healthier lives globally.